Growth Metrics

Foghorn Therapeutics (FHTX) Receivables - Other (2021)

Foghorn Therapeutics (FHTX) has 1 years of Receivables - Other data on record, last reported at $300.0 million in Q4 2021.

  • For Q4 2021, Receivables - Other changed N/A year-over-year to $300.0 million; the TTM value through Dec 2021 reached $300.0 million, changed N/A, while the annual FY2021 figure was $300.0 million, N/A changed from the prior year.
  • Receivables - Other reached $300.0 million in Q4 2021 per FHTX's latest filing.
  • Across five years, Receivables - Other topped out at $300.0 million in Q4 2021 and bottomed at $300.0 million in Q4 2021.